Earnings · US stocks
Enliven Therapeutics, Inc. (ELVN) earnings
Enliven Therapeutics, Inc. published its quarterly report on 2026-11-05. The stock moved +14.31% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-05
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +10.36% | — |
| 3 days | +14.31% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 4 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +1.49%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-05 | -0.36 | +16.89% | +14.31% | — | — |
| 2026-08-05 | -0.49 | -29.80% | -0.47% | -15.85% | -14.91% |
| 2026-05-07 | -0.38 | +7.32% | +4.99% | +14.07% | +12.32% |
| 2026-03-03 | -0.48 | -1.05% | +2.40% | +52.87% | +49.99% |
| 2025-11-12 | -0.32 | +31.18% | +7.19% | -19.70% | -20.72% |
| 2025-08-13 | -0.49 | -16.67% | -1.18% | -7.08% | -9.12% |
| 2025-05-14 | -0.57 | -13.03% | -15.28% | +3.97% | -0.68% |
| 2025-03-13 | -0.46 | +11.11% | -0.05% | -10.25% | -10.11% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.